Cognitive & Nootropic / side effects and safety / Last reviewed 2026-06-02

Pinealon Side Effects: Safety Signals and Warnings

Pinealon safety concerns are compound-specific. The main listed side effects are Mild drowsiness, Headache (rare), and Vivid dreams. The main warning signals are Research is almost exclusively from Russian institutions with limited independent replication, No human clinical trials have been conducted, and Long-term safety profile is unknown.

Read the full Pinealon guide Browse answer pages

Direct Answer

Evidence for Pinealon is too preliminary to support a research protocol with confidence. All data originates from a single Russian research group (Khavinson et al.) with no independent replication by Western or Asian research programs. The regulatory context and peer review standards differ substantially. Of the Cognitive & Nootropic compounds in this library, cerebrolysin has far more RCT data from independent groups.

Evidence grade
Level D
Research status
Early Research
Category
Cognitive & Nootropic
Best for
Neuroprotective peptide research (Russian data only)

Reported Side Effects

Warnings

Known or Plausible Interactions

Regulatory Context

Unregulated research peptide in most countries; available as a supplement in Russia.

Evidence Snapshot

Evidence gradeLevel D
Research statusEarly Research
Best supported outcomesNeuroprotection Under Hypoxia (Level D), Memory and Learning (Level D), and Circadian Rhythm Regulation (Level D)
Primary citation count2
Last reviewed2026-06-02

Related Guides

How to Cite This Page

ExaminePeptides. "Pinealon Side Effects: Safety Signals and Warnings." Last reviewed 2026-06-02. https://examinepeptides.com/answers/pinealon-side-effects-safety/

This static answer page is built for fast indexing and direct citation. It summarizes the matching full evidence review and links back to primary sources where the source database includes them.